O'Neil Global Advisors, Inc. Horizon Therapeutics Public LTD CO Transaction History

O'Neil Global Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 12, 2022	SELL	$79.4 - $116.36 $516,100 - $756,340	-6,500 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $392,692 - $498,976	4,544 Added 232.31%	6,500 $684,000
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $349,296 - $424,961	-3,544 Reduced 64.44%	1,956 $211,000
Q3 2021 Nov 02, 2021	BUY	$91.91 - $110.37 $505,505 - $607,035	5,500 New	5,500 $602,000
Q2 2021 Jul 12, 2021	SELL	$86.24 - $95.92 $319,864 - $355,767	-3,709 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $266,417 - $354,135	3,709 New	3,709 $341,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.